In the landmark STEP 1 trial (Once-Weekly Semaglutide in Adults with Overweight or Obesity, Wilding and colleagues, New England Journal of Medicine , 2021), 1,961 adults who took weekly semaglutide (2.4 mg) plus lifestyle support lost a mean of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo, and 86% achieved at least 5% weight loss
Needle-free jet injectors like the Comfort-in are now available to make injecting for children (including self-administered injections) a simple, safe and stress-free process
[11] Eli Lilly and Company, 'The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)', ClinicalTrials.gov identifier NCT06383390
This can help catch any unexpected changes early, making it easier to manage your health
How to evaluate retatrutide vendors online This section is the most important in this entire guide
You can track the latest updates on retatrutide availability as trials progress